Helicobacter pylori virulence factor CagA (cytotoxin-associated gene A) is a 120-145kDa protein encoded on the 40kb cag pathogenicity island (PAI). H. pylori strains can be divided into CagA positive or negative strains, of which around 60% of H. pylori isolates in Western countries are positive, whereas the majority of East Asian isolates are positive.
The cag PAI also encodes for a type 4 secretion system which is used to "inject" CagA into a target cell upon H. pylori attachment. After translocation, CagA localises to the inner surface of the cell membrane and undergoes tyrosine phosphorylation by Src family kinases (e.g. Fyn and Lyn).
Role in Cancer
H. pylori infection is associated with MALT lymphoma and gastric adenocarcinoma and CagA is thought to be involved in cancer development. Phosphorylated CagA is able to interact with the SHP-2 tyrosine phosphatase, rendering it functionally active, triggering a host cell morphological change to a more motile phenotype known as the "hummingbird phenotype". This phenotype mimics an effect produced by hepatocyte growth factor which may participate in various aspects of cancer, including metastasis.
- Hatakeyama, M. & Higashi, H. (2005). "Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis". Cancer Science 96: 835–843. doi:10.1111/j.1349-7006.2005.00130.x. PMID 16367902.
- Lax, A. (2005). "Bacterial toxins and cancer — a case to answer?". Nature Reviews Microbiology 3: 343–349. doi:10.1038/nrmicro1130. PMID 15806096.